// App-Quantinova.ai

TCT-56 : PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis - 9-Month Angiographic and 12-Month Clinical Results

Researchers

Presenter

  • Bo Xu

Principal Investigators

  • Run-Lin Gao

  • Jia-an Wang

  • Junbo Ge

  • Yuejin Yang

  • Shao Liang Chen

  • Bin Liu

  • Fang Chen

  • Zhanquan Li

  • Yaling Han

  • Guosheng Fu

  • Yelin Zhao

Medical Centers

  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

  • Liaoning Provincial Tumor Hospital, Shenyang, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • Huashan Hospital, Fudan University, Shanghai, China

  • Affilaited Anzhen Hospital of Capital Medical University, Beijing, China

  • Jilin University the Second Hospital, Changchun, China

  • Shenyang Northern Hospital, Shenyang City, China, Shenyang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Restenosis

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Paclitaxel

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved